Clinical trial research, like medicine more generally in the European Union (EU), is regulated by a network of national competent authorities ...

EVRY, France--(BUSINESS WIRE)--Atamyo Therapeutics, a clinical-stage biotechnology company focused on the development of new-generation gene therapies targeting muscular dystrophies and ...

Already since 31 January 2023 all applications for new clinical trials must be submitted under the legal framework of the Clinical Trials Regulation (Regulation EU/536/2014, CT Regulation). By 31 ...

Biodexa Pharmaceuticals PLC (BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced the ...

The European clinical trial landscape will take centre stage this October as leading voices from the biopharma and healthcare sectors convene in Copenhagen, Denmark, for the annual Outsourcing in ...

COPENHAGEN, Aug. 26, 2025 /PRNewswire/ -- Curasight A/S ("Curasight" or "the Company") (CPH: CURAS), a clinical stage radiopharmaceuticals company, today announced the European Medicines Agency (EMA) ...

- ABILITY-1 study is currently enrolling patients for the treatment of advanced solid tumors with MDNA11, a novel long-acting IL-2 super-agonist, as a monotherapy or in combination with KEYTRUDA ®, at ...

November 24, 2025Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP Biodexa ...